Enjoy Free Shipping on Orders above $220
10% off on orders over $120 up to $20 Use Code: MYVAL10
Moxiford 5 ml eye drops contain Moxifloxacin (0.5% w/v) as its active ingredient, which is a fourth-generation fluoroquinolone antibiotic. This advanced antibiotic class offers enhanced activity against a broader spectrum of bacteria than earlier generations, making it highly effective for ophthalmic therapy. Leeford Healthcare Ltd produces Moxiford 0.5% 5 ml under GMP-compliant facilities.
These ophthalmic drops are indicated for treating various bacterial eye infections, including acute bacterial Conjunctivitis (pink eye), corneal ulcers, Keratitis, and other infections involving the eye's external structures. The medication functions by disrupting essential bacterial enzymes, DNA gyrase and topoisomerase IV, that bacteria require for genetic replication and cellular maintenance.
Without functional enzymes, bacterial cells cannot multiply or survive, resulting in infection clearance. Moxifloxacin demonstrates excellent efficacy against common ocular pathogens, including Staphylococcus species and Haemophilus influenzae.
Standard treatment involves applying 1 drop to the infected eye 3 times daily for approximately 1 week, though treatment duration may vary based on clinical response and infection severity. Patients often observe symptomatic relief within two days of initiating therapy.
Commonly reported side effects include a brief stinging sensation, minor ocular irritation, dry eye feeling, and transient vision blur following administration, all of which typically resolve quickly. Before using Moxiford, disclose any previous allergic reactions to fluoroquinolone medications or other antibiotics to your healthcare provider.
Contact lens users must remove their lenses before instilling drops and should not reinsert them until the infection has cleared, unless otherwise directed. Store Moxiford 0.5% 5 ml away from heat and direct sunlight in a dry environment at temperatures not exceeding 25°C. Maintain the bottle cap tightly closed when not in use, keep it out of reach of children, and discard the product 4 weeks after opening.
Moxiford provides valuable benefits for bacterial eye infection management, such as:
Moxiford requires a prescription and should be administered following your healthcare professional's specific instructions. General usage guidelines include:
Moxiford eye drop is currently available in a single-strength formulation. However, you can consider these effective alternatives available at Cheap Medicine Shop:
| Milflox 0.5% 5 ml | $4.56/eye drop |
| Vigamox 5 ml | $12.05/eye drop |
Moxiford may cause mild side effects that resolve without intervention. However, consult a healthcare professional if they persist or worsen:
Liver Disease
Patients with liver conditions can safely use Moxiford 0.5% 5 ml, as topical ocular administration results in minimal systemic absorption. However, notify the healthcare provider of liver disease to ensure appropriate clinical monitoring throughout treatment.
Kidney Impairment
Moxiford 0.5% 5 ml poses no specific concerns for patients with kidney disease, as it is applied locally with negligible systemic absorption. However, inform the ophthalmologist about kidney impairment to ensure safety.
Pregnant and Breastfeeding women
Pregnant or breastfeeding women should use Moxiford 0.5% 5 ml only when clearly indicated and under medical supervision. While topical administration minimizes systemic exposure, fluoroquinolones require careful evaluation during pregnancy and lactation. Consult your healthcare provider to assess risks versus benefits.
Avoid
Avoid allowing the dropper tip to come into contact with the eye, fingers, or other surfaces to prevent bacterial contamination. Patients with documented fluoroquinolone allergy or Moxifloxacin hypersensitivity should not use this medication. Do not wear contact lenses during active infection treatment. Avoid prolonging treatment beyond medical recommendations, as this may encourage antibiotic resistance or secondary fungal infections.
Treatment with Moxiford 0.5% 5 ml typically lasts five to seven days, though your ophthalmologist may adjust the duration based on infection severity and clinical progress. Complete the full course even if symptoms disappear earlier to prevent infection recurrence and antibiotic resistance.
No, Moxiford 0.5% 5 ml specifically treats bacterial eye infections and is ineffective against viral, fungal, or parasitic causes. Accurate diagnosis by your ophthalmologist ensures appropriate treatment selection. Using antibiotics for non-bacterial conditions provides no benefit and may cause harm.
Yes, brief stinging or mild burning upon application is common with Moxiford 0.5% 5 ml and usually subsides within moments. This reaction occurs when the formulation of the eye drops comes into contact with sensitive eye tissues. If stinging becomes severe or prolonged, contact your healthcare provider.
Moxiford 0.5% 5 ml may cause temporary blurring of vision immediately after application. Avoid driving or operating machinery until your vision returns to normal, which typically occurs within minutes. If blurred vision persists longer, consult your ophthalmologist.
If symptoms worsen or fail to improve within 2 to 3 days of treatment, contact your ophthalmologist promptly. Worsening may indicate antibiotic resistance, incorrect diagnosis, or complications requiring alternative therapy or additional evaluation.
Yes, children aged 1 and above can use Moxiford eye drops for bacterial eye infections under proper medical guidance. Pediatric dosing and duration will be determined by the ophthalmologist based on the child's age and infection characteristics. Parental supervision ensures correct application.
No, Moxiford 0.5% 5 ml should only be used to treat active bacterial eye infections, not for prevention. Prophylactic antibiotic use without infection contributes to resistance development and offers no protective benefit. Use only when prescribed for diagnosed infections.
